Medicine and Science from The BMJ cover image

Talk Evidence - Recurrent VTE, CRP testing for COPD, CMO report, and a consultation

Medicine and Science from The BMJ

00:00

CRPC Reactive Protein Testing for COPD Exacerbations

Two things to start extending treatment for unprovoked VTE. For every twenty people you treat you can reduce one venous thromboembolism. Absolute risk reduction of about five percent. Pragmatic trials in the NHS. CRPC reactive protein testing to guide antibiotic persubarobene for COPD exacerbations.

Play episode from 12:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app